# A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma

> **NCT01677858** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 116 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Carfilzomib
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01677858
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-04
- **Primary completion:** 2016-07-22
- **Final completion:** 2018-10-31
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2022-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677858, "A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01677858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*